Recruiting Pulmonary Embolism Studies in Tempe
A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. ...
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....
About Pulmonary Embolism Clinical Trials in Tempe
Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.
There are currently 2 pulmonary embolism clinical trials recruiting participants in Tempe, AZ. These studies are seeking a combined 13,900 participants. Research is being sponsored by Boehringer Ingelheim, Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Embolism Clinical Trials in Tempe — FAQ
Are there pulmonary embolism clinical trials in Tempe?
Yes, there are 2 pulmonary embolism clinical trials currently recruiting in Tempe, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Tempe?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tempe research site will contact you about next steps.
Are clinical trials in Tempe free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tempe studies also compensate for your time and travel.
What pulmonary embolism treatments are being tested?
The 2 active trials in Tempe are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.
Data updated March 2, 2026 from ClinicalTrials.gov